Pasithea Therapeutics Corp. (KTTA) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Miami Beach, FL, 美国. 现任CEO为 Tiago Reis Marques.
KTTA 拥有 IPO日期为 2021-09-15, 4 名全职员工, 在 NASDAQ Capital Marke, 市值为 $5.37M.
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
